Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Garber

Showing results (81-90 of 194) with videos related to

Pageof 20
Sort By:
Journal of the National Cancer Institute|September 13, 2007
Gene mutation revelation points to new target for myeloma treatment, studies sayKen Garber
Nature Biotechnology|August 10, 2007
Stroke treatment--light at the end of the tunnel?Ken Garber
Journal of the National Cancer Institute|April 9, 2009
Drugging the Wnt pathway: problems and progressKen Garber
Nature Reviews. Drug Discovery|February 17, 2025
First muscle-growing antibody heads to the FDA, with obesity opportunities on the horizonKen Garber
Nature Biotechnology|March 6, 2024
The glue degradersKen Garber
Science (New York, N.Y.)|August 23, 2014
The cancer drug that almost wasn'tKen Garber
Nature Reviews. Drug Discovery|July 1, 2016
Two pioneering osteoporosis drugs finally approach approvalKen Garber
Nature Biotechnology|March 11, 2016
Natural killer cells blaze into immuno-oncologyKen Garber
Nature Biotechnology|March 7, 2018
Driving T-cell immunotherapy to solid tumorsKen Garber
Science (New York, N.Y.)|May 12, 2018
A new cancer immunotherapy suffers a setbackKen Garber
Pageof 20

Showing results (81-90 of 194) with videos related to

Sort By:
Pageof 20
Journal of the National Cancer Institute|September 13, 2007
Gene mutation revelation points to new target for myeloma treatment, studies sayKen Garber
Nature Biotechnology|August 10, 2007
Stroke treatment--light at the end of the tunnel?Ken Garber
Journal of the National Cancer Institute|April 9, 2009
Drugging the Wnt pathway: problems and progressKen Garber
Nature Reviews. Drug Discovery|February 17, 2025
First muscle-growing antibody heads to the FDA, with obesity opportunities on the horizonKen Garber
Nature Biotechnology|March 6, 2024
The glue degradersKen Garber
Science (New York, N.Y.)|August 23, 2014
The cancer drug that almost wasn'tKen Garber
Nature Reviews. Drug Discovery|July 1, 2016
Two pioneering osteoporosis drugs finally approach approvalKen Garber
Nature Biotechnology|March 11, 2016
Natural killer cells blaze into immuno-oncologyKen Garber
Nature Biotechnology|March 7, 2018
Driving T-cell immunotherapy to solid tumorsKen Garber
Science (New York, N.Y.)|May 12, 2018
A new cancer immunotherapy suffers a setbackKen Garber
Pageof 20